(TheNewswire)
(July 25, 2024) – TheNewswire– Vancouver, BC - Femto Technologies Inc.(Nasdaq: BCAN ) (“ Femto ” or the “ Company ”), aleading innovator in the FemTech industry, is excited to announce thedebut of its flagship feminine wellness product at The AVN Expo,scheduled to take place in Las Vegas this January 2025. Femtogroundbreaking product is set to redefine the standards of femininecare and wellness, showcasing its proprietary SRS (Smart ReleaseSystem) technology utilizing advanced sensors that precisely detect,infuse and personalize wellness substances aiming to support intimacyand wellbeing. Femto's commitment to enhancing women's health andwellbeing through cutting-edge technology is leading the company'sinnovation pipeline and growth route.
Event: The AVN Expo
Date: January 2025
Location: Las Vegas, Nevada
Femto has rapidly emerged as a pioneer in the FemTechsector, dedicated to addressing the unique health and wellness needsof women through innovative and scientifically-backed solutions. Theintroduction of its flagship product marks a significant milestone inthe company's journey to empower women and improve their quality oflife.
AVN is a leading adult entertainment Expo bringingtogether 500+ adult brands alongside content creators, Femto will bepresenting in the ANE section open to qualified industry members,leading vendors and top buyers. The AVN Expo, renowned for its diversearray of exhibitors and forward-thinking atmosphere, provides theperfect platform for Femto to unveil its latest innovation. Attendeeswill have the opportunity to experience firsthand the advancedfeatures and benefits of Femto's new product, which has been designedwith the highest standards of quality, safety, and effectiveness inmind
"We are thrilled to launch our flagship product atThe AVN Expo, a premier event that celebrates innovation andexcellence," explained Yftah ben Yaackov, CEO of Femto. "Ourteam has worked tirelessly to develop a solution that not only meetsbut exceeds the expectations of technology driven personalization forwomen"
Key highlights of Femto's flagship productinclude:
Advanced Technology: Integrating the latest in FemTechinnovation to provide superior wellness support.
User-Centric Design: Engineered to cater to thespecific needs and preferences of women.
Holistic Wellness: Promoting overall wellbeing throughcomprehensive care solutions.
Femto invites all attendees, media representatives, andindustry professionals to visit their booth at The AVN Expo to learnmore about their pioneering product and explore the future of femininewellness.
For more information about Femto and theirgroundbreaking FemTech products, please visit www.femtocorp.com.
About Femto Technologies Inc.
Femto, previously known as BYND Cannasoft, aims tobecome serve a beacon of transformative change in the sphere of femalehealth and wellness. Through proprietary Smart Release Technology anda dedication to creating smart, women-centric products, Femto isestablishing new benchmarks in the wellness industry.
Femto is an Israeli-based integrated softwarecompany. Femto owns and markets "BenefitCRM", a proprietary customer relationship management (CRM)software product enabling small and medium?sized businesses tooptimize their day?to?day business activities such as salesmanagement, personnel management, marketing, call center activities,and asset management.
Femto owns the patent-pending intellectualproperty for the EZ-G device. This therapeutic device uses proprietarysoftware to regulate the flow of low concentrations of CBD oil, hempseed oil, and other natural oils into the soft tissues of the femalereproductive system to potentially treat a wide variety of women'shealth issues. The EZ-G device includes technological advancements asa sex toy with a more realistic experience and the prototype utilizessensors to determine what enhances the users' pleasure. The user cancontrol the device through a Bluetooth app installed on a smartphoneor other portable device. The data will be transmitted and receivedfrom the device to and from the secure cloud using artificialintelligence (AI). The data is combined with other antonymic userpreferences to improve its operation by increasing sexualsatisfaction. Commercialization of the EZ-G device is subject toreceipt of regulatory approvals.
The devices described in this news release are concept devices thatare in the first stage of development and will be subject to testing,experiments and regulatory approvals and therefore there is nocertainty that they will eventually be marketed.
For further information please refer to the Company’s new website: www.femtocorp.com and on SEDAR+: www.sedarplus.ca .
Gabi Kabazo
Chief Financial Officer
Tel: (604) 833-6820
e?mail: ir@femtocorp.com
Cautionary NoteRegarding Forward-Looking Statements
This press release includes certain statements that maybe deemed “forward-looking statements” within the meaning ofSection 27A of the U.S. Securities Act of 1933, as amended, andSection 21E of the U.S. Securities Exchange Act of 1934, as amendedand under Canadian securities laws. When used in this press release,the words “may”, “would”, “could”, “will”,“intend”, “plan”, “anticipate”, “believe”,“estimate”, “expect” and similar expressions are intended toidentify forward?looking statements. Such statements are subject tocertain risks and uncertainties, and actual circumstances, events orresults may differ materially from those projected in suchforward-looking statements.
Although the Company believes the expectationsexpressed in such forward-looking statements are based on reasonableassumptions, such statements are not guarantees of future performance, and actual events or developments may differmaterially from those in forward-looking statements. Suchforward-looking statements necessarily involve known and unknown risksand uncertainties, which may cause the Company’s actual performanceand financial results in future periods to differ materially from anyprojections of future performance or results expressed or implied bysuch forward-looking statements. Such statements reflect the Company'scurrent views with respect to future events and are subject to suchrisks and uncertainties. Many factors could cause actual results todiffer materially from the statements made, including future financialperformance, unanticipated regulatory requests and delays, finalpatents approval, and those factors discussed in filings made by thecompany with the Canadian securities regulatory authorities, including(without limitation) in the company's management's discussion andanalysis for the year ended December 31, 2023 and annual informationform dated April 2, 2024, which are available under the company'sprofile at www.sedarplus.ca, and in the Company’s Annual Report onForm 20-F for the year then ended that was filed with the U.S.Securities and Exchange Commission on April 3, 2024. Should one ormore of these factors occur, or should assumptions underlying theforward-looking statements prove incorrect, actual results may varymaterially from those described herein as intended, planned,anticipated, or expected. We do not intend and do not assume anyobligation to update these forward?looking statements, except asrequired by law. Any such forward-looking statements representmanagement's estimates as of the date of this press release. While wemay elect to update such forward-looking statements at some point inthe future, we disclaim any obligation to do so, even if subsequentevents cause our views to change. Shareholders are cautioned not toput undue reliance on such forward?looking statements.
Copyright (c) 2024 TheNewswire - All rights reserved.